You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Caplacizumab: an anti–von Willebrand factor antibody for the treatment of thrombotic thrombocytopenic purpura
|
|---|---|
| Published in |
American Journal of Health-System Pharmacy, June 2020
|
| DOI | 10.1093/ajhp/zxaa151 |
| Pubmed ID | |
| Authors |
Alyssa L Hollifield, Justin R Arnall, Donald C Moore |
Mendeley readers
The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 29 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 4 | 14% |
| Researcher | 4 | 14% |
| Student > Ph. D. Student | 3 | 10% |
| Student > Master | 3 | 10% |
| Professor > Associate Professor | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 14 | 48% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 4 | 14% |
| Medicine and Dentistry | 3 | 10% |
| Nursing and Health Professions | 3 | 10% |
| Immunology and Microbiology | 2 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 7% |
| Other | 3 | 10% |
| Unknown | 12 | 41% |